|
|
|
Volumn 85, Issue 5, 2000, Pages 449-450
|
|
The clinical utility of epoetin in cancer patients: A matter of perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
CANCER CHEMOTHERAPY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
EDITORIAL;
ERYTHROCYTE TRANSFUSION;
HEALTH CARE COST;
HUMAN;
INTERMETHOD COMPARISON;
MEDICAL ETHICS;
QUALITY ADJUSTED LIFE YEAR;
ANEMIA;
ANTINEOPLASTIC AGENTS;
COST-BENEFIT ANALYSIS;
ERYTHROCYTE TRANSFUSION;
ERYTHROPOIETIN;
HUMANS;
NEOPLASMS;
RECOMBINANT PROTEINS;
|
|
EID: 0033931311
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (5)
|
|
References (10)
|
